Eye drop gel shows promise for skin graft healing, but trial stalls
NCT ID NCT03579160
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether applying 0.25% timolol gel (a beta-blocker eye drop used for glaucoma) to skin grafts could improve healing and appearance after skin cancer surgery. Researchers planned to enroll 82 patients but stopped early with only 10 participants. The goal was to see if the gel helps wounds heal faster and look better compared to standard Vaseline dressing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
0.25% timolol gel
What this could lead to
If it works, this could offer a simple, low-cost way to improve healing and cosmetic outcomes for skin grafts after cancer surgery.
What could go wrong
The trial was terminated early with only 10 participants, so results are very limited. It is unclear if timolol gel is truly effective or safe for this use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOUND HEAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital
Boston, Massachusetts, 02130, United States